Gsa Capital Partners LLP Vericel Corp Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Vericel Corp stock. As of the latest transaction made, Gsa Capital Partners LLP holds 23,495 shares of VCEL stock, worth $786,847. This represents 0.07% of its overall portfolio holdings.
Number of Shares
23,495
Previous 8,593
173.42%
Holding current value
$786,847
Previous $383,000
161.1%
% of portfolio
0.07%
Previous 0.03%
Shares
16 transactions
Others Institutions Holding VCEL
# of Institutions
294Shares Held
54MCall Options Held
35.6KPut Options Held
7.7K-
Black Rock Inc. New York, NY8.06MShares$270 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$119 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.81MShares$94.2 Million3.59% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$82.5 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$81.6 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.58B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...